000 | 00973 a2200289 4500 | ||
---|---|---|---|
005 | 20250517202531.0 | ||
264 | 0 | _c20190508 | |
008 | 201905s 0 0 eng d | ||
022 | _a1532-6535 | ||
024 | 7 |
_a10.1002/cpt.1002 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTornio, Aleksi | |
245 | 0 | 0 |
_aResponse to "Influence of Diabetes on Antiplatelet Drug Efficacy". _h[electronic resource] |
260 |
_bClinical pharmacology and therapeutics _c04 2018 |
||
300 |
_a573 p. _bdigital |
||
500 | _aPublication Type: Letter; Comment | ||
650 | 0 | 4 | _aClopidogrel |
650 | 0 | 4 | _aElectronic Health Records |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aPharmacogenetics |
650 | 0 | 4 | _aPlatelet Aggregation Inhibitors |
650 | 0 | 4 | _aStroke |
700 | 1 | _aPalmer, Colin N A | |
700 | 1 | _aDoney, Alex S F | |
773 | 0 |
_tClinical pharmacology and therapeutics _gvol. 103 _gno. 4 _gp. 573 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/cpt.1002 _zAvailable from publisher's website |
999 |
_c28110546 _d28110546 |